AG
BBH icon

Advisor Group’s VanEck Biotech ETF BBH Stock Holding History

Advisor Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$88K Sell
632
-310
-33% -$40.7K ﹤0.01% 3030
2019
Q3 		$112K Sell
942
-175
-16% -$21.8K ﹤0.01% 2810
2019
Q2 		$144K Sell
1,117
-102
-8% -$12.6K ﹤0.01% 2570
2019
Q1 		$157K Buy
1,219
+100
+9% +$12.6K ﹤0.01% 2478
2018
Q4 		$124K Buy
1,119
+58
+5% +$7.01K ﹤0.01% 2461
2018
Q3 		$144K Sell
1,061
-10
-0.9% -$1.3K ﹤0.01% 2456
2018
Q2 		$128K Sell
1,071
-300
-22% -$35.4K ﹤0.01% 2322
2018
Q1 		$165K Sell
1,371
-85
-6% -$10.7K ﹤0.01% 2129
2017
Q4 		$181K Buy
1,456
+221
+18% +$28.2K ﹤0.01% 2078
2017
Q3 		$166K Sell
1,235
-164
-12% -$21.4K ﹤0.01% 1990
2017
Q2 		$176K Sell
1,399
-30
-2% -$3.62K ﹤0.01% 1879
2017
Q1 		$170K Sell
1,429
-59
-4% -$6.9K ﹤0.01% 1790
2016
Q4 		$161K Sell
1,488
-1,000
-40% -$109K ﹤0.01% 1718
2016
Q3 		$287K Buy
2,488
+3
+0.1% +$342 0.01% 1299
2016
Q2 		$253K Buy
+2,485
New +$265K 0.01% 1286

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Advisor Group's BBH Position: Q4 2019 in Review

Advisor Group reduced its VanEck Biotech ETF (BBH) stake by 33% in Q4 2019, selling an estimated $40.7K and leaving 632 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

Advisor Group first reported a position in BBH in Q2 2016 and has held it in 15 quarters since. The position peaked at $287K in Q3 2016. 87 funds tracked by Wall St. Rank hold BBH as of Q4 2019.

  • Advisor Group held 632 shares of VanEck Biotech ETF worth $88K as of Q4 2019.
  • Advisor Group sold 310 VanEck Biotech ETF shares in Q4 2019, an estimated $40.7K.
  • VanEck Biotech ETF made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3030 holding.
  • Advisor Group first reported a position in VanEck Biotech ETF in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's VanEck Biotech ETF position peaked at $287K in Q3 2016.
  • 87 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.